MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
PMV Pharmaceuticals, Inc. (NASDAQ: PMVP)*
Organization & Developments: PMV Pharmaceuticals
Parents
PMV Pharmaceuticals, Inc. (NASDAQ: PMVP)*
Children
*P53 Mutations Are Found in Approximately Half of All Cancers.
*PMV takes a unique approach to restoring mutated p53
*Structurally Correcting the Precise Geometry of the Protein, Hence, Restoring Its Tumor Suppressing Function.
2024: PMV lays off 30% to fund phase 2 trial of remaining solid tumor drug
2025: PMV Pipeline_rezatapopt (PC14586)FDA Fast Track Designation
2025: The company has no approved products or revenue to date and is advancing its lead candidate, rezatapopt (PC14586), in collaboration with Merck & Company Inc. (NYSE: MRK).
Jumps
Finance & Acquisitions: PMV Pharmaceuticals
Key People: PMV Pharmaceuticals